Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05898334 · ClinicalTrials.gov registry record · NA
Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery
A NA study, sponsored by First Institute of All Medicines.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT05898334: Completed NA study, sponsored by First Institute of All Medicines.
NCT05898334 is a NA study that has completed, run by First Institute of All Medicines. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05898334, a NA study, has completed, sponsored by First Institute of All Medicines.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this clinical research is to verify if the patients with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. The main study questions are: * Can patients with chronic stroke regain life independence by normalizing Activities of Daily Living (ADL). * Can brain-injury and recovery status of the patients with chronic stroke be detected by using an EEG machine. Participants will sleep-rest on a hotel bed energized by Tesla BioHealing Biophoton Generators, and clinical study staff will observe the participant's activities of daily living, as compared to those who will sleep in the hotel room equipped with placebo devices.
Primary Outcome
Regain Life Independence by Normalizing Activities of Daily Living (ADL). Independence is defined as the normalization of activities of daily living (ADL), at which time the participant's total ADL score will be increased at least to 4 from the baseline score of 2 or less. The participant, the caregiver, together with a study physician can make the judgment if she/he can independently perform the daily activity at any time during the study period.
Interventions
- DEVICE Active Biophoton Generators
- DEVICE Inactive Biophoton Generators
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2024-06-28 |
| Phase | NA |
What the finished NCT05898334 record still lists
NCT05898334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Active Biophoton Generators is the first listed.
NCT05898334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05898334 about?
NCT05898334 is a clinical study titled "Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery". The purpose of this clinical research is to verify if the patients with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. The main study questions are: * Can patient...
What is the current status of trial NCT05898334?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2023-05-10. Estimated completion is 2024-06-28.
What interventions are being tested in trial NCT05898334?
The interventions under investigation include: Active Biophoton Generators (DEVICE), Inactive Biophoton Generators (DEVICE).
Who is sponsoring clinical trial NCT05898334?
This trial is sponsored by First Institute of All Medicines, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05898334's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI